Evidence map›Paper›PMID 36290278›Full record

ArticleAnimals : an open access journal from MDPI2022

Compensability of Enhanced Cytoplasmic Droplet Rates in Boar Semen: Insights of a Retrospective Field Study.

Martin Schulze, Dagmar Waberski

Open access · goldAbstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Sperm Quality and Fertility of Livestock Animals.Animals : an open access journal from MDPI · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Martin SchulzeInstitute for Reproduction of Farm Animals Schönow, Bernauer Allee 10, D-16321 Bernau, Germany.ORCID 0000-0001-7932-9412
Dagmar WaberskiUnit for Reproductive Medicine of Clinics, Clinic for Pigs and Small Ruminants, University of Veterinary Medicine Hannover, Bünteweg 15, D-30559 Hannover, Germany.ORCID 0000-0001-6616-2035
University of Veterinary Medicine Hannover, Foundation · DE

Funding

Association for Bioeconomy Research not availble
6 · The paper itself

Abstract

Retained cytoplasmic droplets (CD) provide the most abundant sperm abnormality in boar and reduce fertility. It is still unclear as to whether high CD rates in semen portions are compensable. The aim was to explore the impact of CD in relation to quantitative and qualitative sperm traits on fertility performance of sows. Retrospective data analysis of 1497 inseminations was performed. Ejaculates (n = 260) were assigned to three groups with low (<10%), medium (≥10% to <15%), and high (≥15%) CD rates. Average sperm numbers were lowest in the high CD group (2.08 × 109/mL). Membrane integrity and mitochondrial activity did not differ between the groups. Breakpoint analysis indicated a shift towards lower litter sizes when the CD rate exceeded 11%. Group comparisons revealed no difference in litter size (p = 0.205), together with a slightly higher farrowing rate in the high CD group (p < 0.001), which coincided with higher resistance against temperature stress in the stored semen samples (p < 0.001) and a higher sperm motility (p < 0.001). In conclusion, an increased prevalence of CD in boar semen is compensable by high tolerance against temperature stress, whereas sperm numbers per dose are less relevant.

Indexed as

artificial inseminationboar semencold resistancecytoplasmic dropletsheat resistancesperm morphology

Identifiers

PMID36290278
PMCPMC9598426
OpenAlexW4307117555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.